✦ LIBER ✦

OR.2. Epitope-Specific Therapy in Rheumatoid Arthritis, Phase 2 Clinical and Immunological Results

✍ Scribed by Eva Koffeman; Diane Amox; Mark Genovese; Michael Schiff; Carolyn Dennehey; James Posever; Francis Belardi; Ernesto Santana; Jerry Molitor; Joan Bathon; Eric Matteson; Allan Kivitz; Charles Berry; Elissa Keogh; Gisella Puga Yung; Adriana Tremoulet; Peter Zieseniss; Courtney Gosch; Samantha Friend; Alex Martinez; Tho Le; Rodrigo Samodal; Arthur Kavanaugh; Jearanai Sriuma; Xiao Zhang; Berent Prakken; Gary Cutter; Salvatore Albani

Book ID: 116366489
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 83 KB
Volume: 119
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2006.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T.66. Clinical Remission Induced by Epit

T.66. Clinical Remission Induced by Epitope Specific Therapy in Rheumatoid Arthritis is Associated with T Cell Immune Deviation from Pro-inflammatory (TH1/TH17) to Regulatory Phenotype (TH2/Treg)

✍ Theo van den Broek; Nicole Schechter; Cathleen Cover; Norma Seaver; Austin Nicho 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Retrospective clinical study on the nota

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)

✍ Yoshiya Tanaka; Tsutomu Takeuchi; Eisuke Inoue; Kazuyoshi Saito; Naoya Sekiguchi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 252 KB

Cost-effectiveness analysis of NSAIDs, N

Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis

✍ Hyung Ran Yun; Sang-Cheol Bae 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 209 KB

A phase I study of interleukin-2 in chil

A phase I study of interleukin-2 in children with cancer and evaluation of clinical and immunologic status during therapy. A pediatric oncology group study

✍ Sherif Nasr; John McKolanis; Ray Pais; Harry Findley; Robert Hnath; Kathy Waldre 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB

The authors performed a Phase I study to assess the toxicity and hematologic effect of recombinant human interleukin-2 (rIL-2) in seven children with advanced malignancies. The rIL-2 was given as a bolus injection of 1 or 3 X lo6 U/m2/dose three times a week (Monday, Wednesday, and Friday) for 3 wee

Epitope-specific immunotherapy of rheuma

Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial

✍ Eva C. Koffeman; Mark Genovese; Diane Amox; Elissa Keogh; Ernesto Santana; Eric 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

Retrospective clinical study on the nota

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J)

✍ Tsutomu Takeuchi; Hisashi Yamanaka; Eisuke Inoue; Hayato Nagasawa; Masao Nawata; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 283 KB